Key Decisions and Approvals

1. The Board approved the unaudited Financial Statements for the half year ended 30th September 2026 as recommended by the Audit Committee.

2. The Board appointed Banka Goenka & Associates (Firm Registration No:334031E) as the Internal Auditor of the Company for the Financial Year 2026-27. The appointment date is 01st November 2026, and the terms are for carrying out Internal Audit of the Company for FY 2026-2027. The firm is not related to any of the Directors of the Company.

Financial Results Highlights (₹ in Lakhs, except per share data)

Income Statement for Half Year Ended September 30, 2026:

  • Revenue from operations: ₹2,211.87 (vs. ₹1,773.69 in H1 FY26)
  • Other income: ₹24.91 (vs. ₹10.70 in H1 FY26)
  • Total income: ₹2,236.78 (vs. ₹1,784.39 in H1 FY26)
  • Total expenditure: ₹2,026.87 (vs. ₹1,615.83 in H1 FY26)
  • Profit before tax: ₹209.91 (vs. ₹168.56 in H1 FY26)
  • Total tax expense: ₹51.56 (vs. ₹44.14 in H1 FY26)
  • Profit for the period: ₹158.35 (vs. ₹124.42 in H1 FY26)
  • Paid-up equity share capital (Face value ₹10): ₹355.88
  • Earnings per share (Basic & Diluted): ₹4.45 (vs. ₹3.94 in H1 FY26)

Balance Sheet as at September 30, 2026 (₹ in Lakhs):

  • Total Equity & Liabilities: ₹1,991.85 (vs. ₹1,829.35 as at Mar 31, 2026)
  • Total Assets: ₹1,991.85 (vs. ₹1,829.35 as at Mar 31, 2026)
  • Shareholders' Funds: ₹1,350.06 (Equity ₹355.88 + Reserves ₹994.18)
  • Cash and cash equivalents: ₹244.08 (vs. ₹787.98 as at Mar 31, 2026)

Cash Flow Statement for Half Year Ended September 30, 2026 (₹ in Lakhs):

  • Net cash from operating activities: ₹143.92
  • Net cash used in investing activities: (₹600.03)
  • Net cash used in financing activities: (₹87.79)
  • Net decrease in cash and cash equivalents: (₹543.90)

Fund Utilization

IPO Proceeds (Fresh Issue of ₹703.30 Lakhs):

  • Working Capital: Utilized ₹93.00 lakh; ₹302.00 lakh temporarily parked in FD pending utilization.
  • Marketing and Business Promotion: Fully utilized ₹102.00 lakh.
  • General Corporate Purposes: Utilized ₹76.84 lakh; ₹9.46 lakh unutilized and kept in ICICI Escrow Account.
  • Issue related expenses: Fully utilized ₹120.00 lakh.

Preferential Issue Proceeds (₹298.80 Lakhs for Working Capital, Brand Building, Technology Enhancement):

  • The entire amount of ₹298.80 lakh remained unutilized as at September 30, 2026, and has been temporarily invested in fixed deposits pending utilisation.

Auditor's Review and Notes

  • The financial results were reviewed by the statutory auditor, Maheshwari & Co. (Firm Reg. No.105834W), who issued an unmodified review conclusion.
  • Note 7 highlights that certain reimbursement/pass-through recoveries are presented on a gross basis under Revenue from Operations, as they are billed through a single invoice. This has no impact on profit.
  • The company operates in a single business segment of destination management and allied travel services.

Additional Information

  • The financial results will be available on the company website: www.naturewings.com.
  • The filing is made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.